Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Melanoma × Tablets × Clear all

Phase

Status

Unknown 1 Completed 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 2 Vomiting 1 Resectable Pancreatic Ductal Adenocarcinoma 1 Prostatic Neoplasms 1 Neoplasms 1 Nausea 1 Myasthenia Gravis 1 Microbiota 1 Melanoma 1 Hepatitis B 1 Hand-Foot Skin Reaction (HFSR) 1 Glioblastoma 1 Erectile Dysfunction 1 Carcinoma, Non-Small-Cell Lung 1

Interventions

Nivolumab 21 pembrolizumab 16 Ipilimumab 12 Temozolomide 10 toripalimab 8 Blood Specimen Collection 7 Biopsy 7 Dacarbazine 6 Cyclophosphamide 6 trametinib 5 fludarabine 5 dabrafenib 5 camrelizumab 5 atezolizumab 5 durvalumab 4 Interleukin-2 4 Injections 4 Chemotherapy, Adjuvant 4 palbociclib 3 binimetinib 3 apatinib 3 aldesleukin 3 Sorafenib 3 Introns 3 Gene Expression Profiling 3 Cisplatin 3 Carboplatin 3 Canvaxin 3 Bevacizumab 3 tremelimumab 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05370807 2023-10-24

RegoMel

Universitair Ziekenhuis Brussel

Phase 2 Unknown

Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡